Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
© 2024. The Author(s)..
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Nature communications - 15(2024), 1 vom: 08. Feb., Seite 1176 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tamura, Tomokazu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-024-45274-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368216446 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368216446 | ||
| 003 | DE-627 | ||
| 005 | 20240214233253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240209s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-024-45274-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM368216446 | ||
| 035 | |a (NLM)38332154 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tamura, Tomokazu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Codon, Nonsense |2 NLM | |
| 700 | 1 | |a Irie, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Deguchi, Sayaka |e verfasserin |4 aut | |
| 700 | 1 | |a Yajima, Hisano |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuda, Masumi |e verfasserin |4 aut | |
| 700 | 1 | |a Nasser, Hesham |e verfasserin |4 aut | |
| 700 | 1 | |a Mizuma, Keita |e verfasserin |4 aut | |
| 700 | 1 | |a Plianchaisuk, Arnon |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Saori |e verfasserin |4 aut | |
| 700 | 1 | |a Uriu, Keiya |e verfasserin |4 aut | |
| 700 | 1 | |a Begum, Mst Monira |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Ryo |e verfasserin |4 aut | |
| 700 | 1 | |a Jonathan, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Rigel |e verfasserin |4 aut | |
| 700 | 1 | |a Kondo, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Ito, Hayato |e verfasserin |4 aut | |
| 700 | 1 | |a Kamiyama, Akifumi |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshimatsu, Kumiko |e verfasserin |4 aut | |
| 700 | 1 | |a Shofa, Maya |e verfasserin |4 aut | |
| 700 | 1 | |a Hashimoto, Rina |e verfasserin |4 aut | |
| 700 | 1 | |a Anraku, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Kanako Terakado |e verfasserin |4 aut | |
| 700 | 1 | |a Kita, Shunsuke |e verfasserin |4 aut | |
| 700 | 1 | |a Sasaki, Jiei |e verfasserin |4 aut | |
| 700 | 1 | |a Sasaki-Tabata, Kaori |e verfasserin |4 aut | |
| 700 | 1 | |a Maenaka, Katsumi |e verfasserin |4 aut | |
| 700 | 1 | |a Nao, Naganori |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Lei |e verfasserin |4 aut | |
| 700 | 1 | |a Oda, Yoshitaka |e verfasserin |4 aut | |
| 700 | 0 | |a Genotype to Phenotype Japan (G2P-Japan) Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Terumasa |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Akatsuki |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuno, Keita |e verfasserin |4 aut | |
| 700 | 1 | |a Ito, Jumpei |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Shinya |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Kei |e verfasserin |4 aut | |
| 700 | 1 | |a Hashiguchi, Takao |e verfasserin |4 aut | |
| 700 | 1 | |a Takayama, Kazuo |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuhara, Takasuke |e verfasserin |4 aut | |
| 700 | 1 | |a Sawa, Hirofumi |e investigator |4 oth | |
| 700 | 1 | |a Kawabata, Ryoko |e investigator |4 oth | |
| 700 | 1 | |a Watanabe, Yukio |e investigator |4 oth | |
| 700 | 1 | |a Sakamoto, Ayaka |e investigator |4 oth | |
| 700 | 1 | |a Yasuhara, Naoko |e investigator |4 oth | |
| 700 | 1 | |a Suzuki, Tateki |e investigator |4 oth | |
| 700 | 1 | |a Nakajima, Yukari |e investigator |4 oth | |
| 700 | 1 | |a Ferdous, Zannatul |e investigator |4 oth | |
| 700 | 1 | |a Shishido, Kenji |e investigator |4 oth | |
| 700 | 1 | |a Mugita, Yuka |e investigator |4 oth | |
| 700 | 1 | |a Takahashi, Otowa |e investigator |4 oth | |
| 700 | 1 | |a Ichihara, Kimiko |e investigator |4 oth | |
| 700 | 1 | |a Kaku, Yu |e investigator |4 oth | |
| 700 | 1 | |a Misawa, Naoko |e investigator |4 oth | |
| 700 | 1 | |a Guo, Ziyi |e investigator |4 oth | |
| 700 | 1 | |a Hinay, Alfredo |c Jr |e investigator |4 oth | |
| 700 | 1 | |a Kosugi, Yusuke |e investigator |4 oth | |
| 700 | 1 | |a Fujita, Shigeru |e investigator |4 oth | |
| 700 | 1 | |a Tolentino, Jarel M |e investigator |4 oth | |
| 700 | 1 | |a Chen, Luo |e investigator |4 oth | |
| 700 | 1 | |a Pan, Lin |e investigator |4 oth | |
| 700 | 1 | |a Suganami, Mai |e investigator |4 oth | |
| 700 | 1 | |a Chiba, Mika |e investigator |4 oth | |
| 700 | 1 | |a Yoshimura, Ryo |e investigator |4 oth | |
| 700 | 1 | |a Yasuda, Kyoko |e investigator |4 oth | |
| 700 | 1 | |a Iida, Keiko |e investigator |4 oth | |
| 700 | 1 | |a Ohsumi, Naomi |e investigator |4 oth | |
| 700 | 1 | |a Strange, Adam P |e investigator |4 oth | |
| 700 | 1 | |a Shibatani, Yuki |e investigator |4 oth | |
| 700 | 1 | |a Nishiuchi, Tomoko |e investigator |4 oth | |
| 700 | 1 | |a Tanaka, Shiho |e investigator |4 oth | |
| 700 | 1 | |a Putri, Olivia |e investigator |4 oth | |
| 700 | 1 | |a Joas, Gustav |e investigator |4 oth | |
| 700 | 1 | |a Kim, Yoonjin |e investigator |4 oth | |
| 700 | 1 | |a Yamasoba, Daichi |e investigator |4 oth | |
| 700 | 1 | |a Yoshimura, Kazuhisa |e investigator |4 oth | |
| 700 | 1 | |a Sadamasu, Kenji |e investigator |4 oth | |
| 700 | 1 | |a Nagashima, Mami |e investigator |4 oth | |
| 700 | 1 | |a Asakura, Hiroyuki |e investigator |4 oth | |
| 700 | 1 | |a Yoshida, Isao |e investigator |4 oth | |
| 700 | 1 | |a Nakagawa, So |e investigator |4 oth | |
| 700 | 1 | |a Takaori-Kondo, Akifumi |e investigator |4 oth | |
| 700 | 1 | |a Shirakawa, Kotaro |e investigator |4 oth | |
| 700 | 1 | |a Nagata, Kayoko |e investigator |4 oth | |
| 700 | 1 | |a Nomura, Ryosuke |e investigator |4 oth | |
| 700 | 1 | |a Horisawa, Yoshihito |e investigator |4 oth | |
| 700 | 1 | |a Tashiro, Yusuke |e investigator |4 oth | |
| 700 | 1 | |a Kawai, Yugo |e investigator |4 oth | |
| 700 | 1 | |a Ueno, Takamasa |e investigator |4 oth | |
| 700 | 1 | |a Motozono, Chihiro |e investigator |4 oth | |
| 700 | 1 | |a Toyoda, Mako |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 15(2024), 1 vom: 08. Feb., Seite 1176 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:08 |g month:02 |g pages:1176 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-024-45274-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 08 |c 02 |h 1176 | ||